Impact of Chlorella vulgaris Supplementation on Health Outcomes in Individuals with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Evaluated by GRADE - Scorecard - MDSpire
Advertisement
Impact of Chlorella vulgaris Supplementation on Health Outcomes in Individuals with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Evaluated by GRADE
Clinical Scorecard: Impact of Chlorella vulgaris Supplementation on Health Outcomes in Individuals with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Evaluated by GRADE
At a Glance
Category
Detail
Condition
Non-Alcoholic Fatty Liver Disease (NAFLD)
Key Mechanisms
Excessive fat accumulation in the liver linked to metabolic disorders.
Target Population
Adults with NAFLD
Care Setting
Clinical research settings
Key Highlights
NAFLD affects 10% to 35% of the global population.
C. vulgaris may improve lipid metabolism and inflammatory biomarkers.
Lifestyle modifications remain the cornerstone of NAFLD treatment.
The study employs the GRADE framework for evidence assessment.
More research is needed to confirm long-term benefits of C. vulgaris.
Guideline-Based Recommendations
Diagnosis
Use of NAFLD terminology in studies conducted prior to 2023.
Management
Lifestyle modifications including diet and physical activity.
Monitoring & Follow-up
Assess cardiovascular risk factors and liver function tests.
Risks
Progression to NASH, fibrosis, cirrhosis, and hepatocellular carcinoma.
Patient & Prescribing Data
Adults diagnosed with NAFLD.
C. vulgaris supplementation may support cardiovascular health.
Clinical Best Practices
Conduct RCTs to evaluate the efficacy of nutritional supplements.
Utilize the GRADE framework for assessing evidence quality.
